| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/28/2002 | US20020038468 Expression vector for use in generating animal models which are mutant in pain response |
| 03/28/2002 | US20020038467 Transgenic mice containing melanocyte stimulating hormone receptor gene disruptions |
| 03/28/2002 | US20020038466 Transgenic mice containing magnesium dependent protein phosphatase gene disruptions |
| 03/28/2002 | US20020038013 Can be used for diagnosis, drug screening, clinical trial monitoring and the treatment of physiological disorders |
| 03/28/2002 | US20020038012 Can be used for diagnosis, drug screening, clinical trial monitoring and the treatment of physiological disorders |
| 03/28/2002 | US20020038007 Method of finding agonist and antagonist to human 11cb splice variant |
| 03/28/2002 | US20020038006 Human extracellular matrix proteins |
| 03/28/2002 | US20020038005 For using the genes, for example in microorganisms to control insect pests or in transgenic plants to confer insect resistance |
| 03/28/2002 | US20020038003 Novel antibody recognizing a small subset of human hematopoietic cells |
| 03/28/2002 | US20020038002 To suppress immune system for therapy of symptoms associated with immune disorders such as allergies, transplanted tissue rejection and autoimmune diabetes, rheumatoid arthritis and multiple sclerosis |
| 03/28/2002 | US20020038000 Systematic polypeptide evolution by reverse translation |
| 03/28/2002 | US20020037920 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
| 03/28/2002 | US20020037908 For solubilizing a conformationally altered protein, comprising a carboxylic acid anion of picolinic acid, its analogs, or derivatives thereof and a cation; treating Alzheimer's disease or Creutzfelds-Jakob disease for example |
| 03/28/2002 | US20020037870 Method of inhibiting cancer cell growth using a vector expressing pRb2/p130 |
| 03/28/2002 | US20020037869 Human bad polypeptides, encoding nucleic acids and methods of use |
| 03/28/2002 | US20020037853 Polypeptides |
| 03/28/2002 | US20020037852 Anticarcinogenic agents |
| 03/28/2002 | US20020037851 Codes with nucleic acids; antiinflammatory agents |
| 03/28/2002 | US20020037850 Genetic engineering; binding to antibodies |
| 03/28/2002 | US20020037849 Anticholesterol agents; hypotensive agents; polypeptide |
| 03/28/2002 | US20020037845 Polypeptide with appetite regulating activity |
| 03/28/2002 | US20020037844 Synthetic peptide for treatment of autoimmune arthritis |
| 03/28/2002 | US20020037841 Blood disorders; drug in aqueous solution |
| 03/28/2002 | US20020037840 Fusion protein |
| 03/28/2002 | US20020037839 Antiischemic agents; hypotensive agents; antiiflammatory agents |
| 03/28/2002 | US20020037833 Administering botulinium toxin component coupled to substance P |
| 03/28/2002 | US20020037585 Detecting modulator of preferential gene expression; obtain cell from human or nematode, incubate cells with modulator, monitor cells for decrease in preferential gene expresssion |
| 03/28/2002 | US20020037583 Transforming cells with preferfential nucleotide sequences; obtain cells, transform, with vector, express vector, recover preferential proteins |
| 03/28/2002 | US20020037582 Potential effector for the grb7 family of signalling proteins |
| 03/28/2002 | US20020037574 Recombinant C-proteinase and processes, methods and uses thereof |
| 03/28/2002 | US20020037567 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of collagen defects |
| 03/28/2002 | US20020037558 Generating genetically engineered antibodies from prokaryotes; provide prokaryote, transform, culture cells, recover genetically engineered antibodies |
| 03/28/2002 | US20020037557 Nucleotide sequences which code proteins for use in the treatment of nervous system, cardiovascular and liver disorders; for use in treatment of burns, traumatic injuries, surgery and ulcers |
| 03/28/2002 | US20020037556 Heliothis virescens ultraspiracle (USP) protein |
| 03/28/2002 | US20020037553 Fragments of leptin (ob protein) |
| 03/28/2002 | US20020037551 Polypeptide; for use in diagnosis and treatment of infections, anemia, nephritis, respiratory and cardiovascular disorders |
| 03/28/2002 | US20020037550 Molecular cloning of a mouse seven transmembrane receptor (AXOR70) |
| 03/28/2002 | US20020037549 ABC transport polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | US20020037548 Peptide; for use as diagnostic tool in human therapeutics |
| 03/28/2002 | US20020037541 Isolated nucleic acid molecules associated with gastric cancer and methods for diagnosing and treating gastric cancer |
| 03/28/2002 | US20020037537 Measuring activity of endothelial growth factor modulator; obtain modulator, incubate with kinase, isolate phosphorylated substrate, remove label, detecting adjustment in kinase activity |
| 03/28/2002 | US20020037535 Contacting the cells (other than cancer cells and megakaryocyte progenitor cells) with a modified C-reactive protein or a mutant or mutant, modified C-reactive protein; in vitro or in vivo; |
| 03/28/2002 | US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections |
| 03/28/2002 | US20020037523 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of nervous system, autoimmune, inflammation, glomerulonephritis and osteoporosis disorders |
| 03/28/2002 | US20020037522 Protein; for use in the prevention of antibiotic resistance in cancer therapy |
| 03/28/2002 | US20020037518 Polypeptide for use in the diagnosis, prevention and treatment of cell proliferation and inflammation defects |
| 03/28/2002 | US20020037515 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals |
| 03/28/2002 | US20020037503 Reagents and methods useful for detecting diseases of the breast |
| 03/28/2002 | US20020037326 Peptides for inhibiting retroviruses |
| 03/28/2002 | US20020037315 Transforming or transfecting cells with an anti-sense reagent capable of reducing Asp2 (Aspartyl protease 2) polypeptide production by reducing Asp2 transcription or translation in the cells for reducing cellular production of amyloid beta |
| 03/28/2002 | US20020037294 To protect animals from diseases caused by parasitic helminths, such heartworm disease |
| 03/28/2002 | US20020037293 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/28/2002 | US20020037292 Avian polynucleotide vaccine formula |
| 03/28/2002 | US20020037288 As therapeutic agents for T cell tumors or B cell tumors (excluding myeloma) |
| 03/28/2002 | US20020037287 For diagnosis and therapy of myeloma and ovarian cancer |
| 03/28/2002 | US20020037286 Methods for altering T cell and macrophage activation |
| 03/28/2002 | US20020037254 Conjugate for differentiating between healthy and unhealthy tissue |
| 03/28/2002 | US20020037250 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 03/28/2002 | DE10112098A1 Neue für das chrA-Gen kodierende Nukleotidsequenzen New coding for the CHRA gene nucleotide sequences |
| 03/28/2002 | DE10108839A1 Neue für das sugA-Gen kodierende Nukleotidsequenzen New coding for the Suga gene nucleotide sequences |
| 03/28/2002 | DE10106829A1 Arzneimittel mit einer für das RNA-bindende KOC-Protein kodierenden DNA-Sequenz, einem KOC-Protein oder einer DNA-Sequenz des KOC-Promotors Drugs with a gene encoding the RNA binding protein KOC-DNA sequence, a protein or KOC a DNA sequence of the promoter KOC |
| 03/28/2002 | DE10053785A1 Testsysteme und deren Verwendung zur Identifizierung und Charakterisierung von Verbindungen Test systems and their use for the identification and characterization of compounds |
| 03/28/2002 | DE10046623A1 New dps gene of coryneform bacteria, useful when overexpressed, for increasing fermentative production of L-amino acids, encodes a DNA-protection protein |
| 03/28/2002 | DE10046400A1 Neuronal exprimiertes Protein und seine Verwendung Neuronal expressed protein and its use |
| 03/28/2002 | DE10046083A1 Am Nukleotidmetabolismus beteiligte Proteine und dafür codierende Gene aus ASHBYA GOSSYPII At the nucleotide metabolism genes coding for proteins and from ASHBYA GOSSYPII involved |
| 03/28/2002 | DE10045935A1 New two-chain protein isolated from Bitis gabonica rhinoceros venom by cation exchange chromatography, useful as specific inhibitor of the intrinsic blood coagulation system |
| 03/28/2002 | DE10045592A1 Ein Antikörper-TNF-TNF Inhibitor Fusionsprotein (TNF-Selektokin) als zielspezifisches Prozytokin zur Tumortherapie An antibody-TNF TNF inhibitor fusion protein (TNF-Selektokin) as target-specific Prozytokin for tumor therapy |
| 03/28/2002 | DE10045016A1 New retroviral vector, useful e.g. in gene therapy, comprises a foreign sequence between primer binding site and splice donor, has better efficiency of gene expression |
| 03/28/2002 | DE10042609A1 Verwendung von T-Proteinen zur differentiellen Charakterisierung und Therapie von Verletzungen und Tumoren des Nervensystems The use of T-proteins for differential characterization, and therapy of injuries and tumors of the nervous system |
| 03/28/2002 | DE10042598A1 Rekombinantes MVA mit der Fähigkeit zur Expression des HER-2/Neu-GENS The recombinant MVA with the ability to express the HER-2 / neu gene |
| 03/28/2002 | DE10042447A1 Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports Protein from the intestines of vertebrates, which absorbs cholesterol, as well as use of this protein for the identification of inhibitors of intestinal cholesterol transport |
| 03/28/2002 | DE10028376A1 Epididymis-spezifische Proteine mit Fibronektin Typ II-Modulen Epididymis-specific proteins with fibronectin type II modules |
| 03/28/2002 | CA2632702A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/28/2002 | CA2460014A1 Spas-1 cancer antigen |
| 03/28/2002 | CA2427490A1 Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr) |
| 03/28/2002 | CA2424394A1 Growth factor complex comprising an insulin-like growth factor binding protein bound to vitronectin |
| 03/28/2002 | CA2423181A1 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof |
| 03/28/2002 | CA2423161A1 Glutaryl cephalosporin amidase from pseudomonas diminuta bs-203 |
| 03/28/2002 | CA2423127A1 Immunogen comprising ligand bound hiv envelope protein |
| 03/28/2002 | CA2423117A1 Preparation of capped mrna |
| 03/28/2002 | CA2423111A1 Means for the identification of compounds capable of inhibiting karap-transduced signals |
| 03/28/2002 | CA2423108A1 .beta.-catenin nuclear localizing protein |
| 03/28/2002 | CA2423104A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/28/2002 | CA2423090A1 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | CA2422921A1 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 03/28/2002 | CA2422911A1 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | CA2422902A1 Modified factor viii |
| 03/28/2002 | CA2422740A1 G-protein coupled receptor hfrbn63 |
| 03/28/2002 | CA2422631A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/28/2002 | CA2422568A1 Prognostic indicator |
| 03/28/2002 | CA2422564A1 Influenza a virus haemagglutinin subtype h16 proteins and their encoding nucleic acid |
| 03/28/2002 | CA2422541A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/28/2002 | CA2422508A1 Atp-binding cassette protein |
| 03/28/2002 | CA2422487A1 Rice mlh1 ortholog and uses thereof |
| 03/28/2002 | CA2422451A1 Haemophilus influenzae basb202 polypeptide, production, vaccine and diagnostic use |
| 03/28/2002 | CA2422215A1 B7-like molecules and uses thereof |
| 03/28/2002 | CA2421877A1 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen |
| 03/28/2002 | CA2421865A1 Olfactory and pheromones g-protein coupled receptors |
| 03/28/2002 | CA2421576A1 Human polynucleotides and polypeptides encoded thereby |
| 03/28/2002 | CA2421249A1 21 human secreted proteins |